European Biotechnology: 'A pioneering real AI drug discovery technology'

by Som Biotech

4 years ago
SOMAI PRO, AI, technologies, treatments, covid-19, drugs

European Biotechnology Life Science and Industry Magazine published the article “A pioneering real AI drug discovery technology” describing the approach of SOM Biotech.

Nobel’s next nominees? Six impactful discoveries that could be future winners

by CAS, a division of the American Chemical Society

4 years ago
CRISPR, Nobel, Chemistry, discoveries, grow food, diagnose, treatments

This week, the 2020 Nobel Prize in Chemistry was awarded to Emmanuelle Charpentier and Jennifer A. Doudna for their foundational discovery of CRISPR gene-editing technology. This technology has had wi...

ALKBH3 biomarker helps predict Hodgkin lymphoma aggressiveness

by Hospital Universitari de Bellvitge

4 years ago
Pharmacological, IDIBELL, ICO, Hodgkin lymphoma, treatments, biomarker

Dysregulation of RNA and protein levels, compared to normal tissues, is a consistent molecular feature of all cancers. Behind the causes of these changes, chemical modifications have recently been ide...

SOM Biotech has attended the virtual workshop on the World Duchenne Awareness Day 2020

by Som Biotech

4 years ago
drug development, R&D process, collaboration, treatments, Duchenne Parent Project

SOM Biotech has attended the virtual V Workshop “Duchenne and the Brain” organized by the Duchenne Parent Project Spain on September 7th, on the occasion of the World Duchenne Awareness Day 2020.

Almirall calls for innovation to advance new treatments for skin diseases

by CataloniaBio

4 years ago
treatments, skin diseases, Almirall

Almirall, a global pharmaceutical company member of CataloniaBio & HealthTech, launches its fifth call AlmirallShare to establish collaborations in research and identify new treatments for skin health...

Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis

by Galchimia

4 years ago
drug, visceral leishmaniasis, GlaxoSmithKline, treatments

We are happy to share our latest report from the work carried out in collaboration with GlaxoSmithKline and the Drug Discovery Unit of the University of Dundee. The paper published in RSC Medicinal Ch...

Sant Pau has initiated more than 30 research projects on the new coronavirus

by Hospital de la Santa Creu i Sant Pau

5 years ago
coronavirus, research, pathologies, treatments, patients

The Sant Pau Institute for Biomedical Research (IIB Sant Pau) has initiated more than 30 research projects to combat and learn more about the new coronavirus and Covid-19 disease. The projects are dev...

VHIO: driving the development of pioneering cell therapies for non-responders to current immunotherapies

by VHIO

5 years ago
killer T lymphocytes, gastrointestinal, treatments, Killer T cells

Research led by VHIO’s Alena Gros signposts a new, less invasive approach to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to a...

Oryzon announces First-Patients-in in CLEPSIDRA: a Phase IIa clinical trial with Iadademstat (ORY-1001) in Small Cell Lung Cancer patients

by Oryzon Genomics

6 years ago
epigenetics, therapies, serious diseases, treatments, patients, ORY-1001, small cell lung cancer, SCLC, CLEPSIDRA

Oryzon Genomics has announced today the inclusion of the first two p atient s in a Phase IIa clinical study with Iadademstat (ORY - 1001) in Small Cell Lung Cancer (SCLC) patients .